Glass House Brands Inc. ( GLASF) - Key Metrics
Stock symbol GLASF is outdated, potentially delisted? Maybe it is available on other exchange?
GLASF Revenue per Share metrics
| Date | Revenue per Share | Net Income per Share | Operating Cash Flow | Free Cash Flow per Share |
|---|---|---|---|---|
| 2026Q1 | ? | ? | ? | ? |
| 2025Q4 | $0.53 | -$0.21 | -$0.05 | -$0.08 |
| 2025Q3 | $0.47 | -$0.15 | -$0.06 | -$0.17 |
| 2025Q2 | $0.74 | $0.11 | $0.22 | $0.10 |
| 2025Q1 | $0.55 | -$0.12 | $0.03 | -$0.05 |
GLASF Payout ratio and Price per Earnings ratio
| Date | Payout ratio | PE ratio |
|---|---|---|
| 2026Q1 | ? | ? |
| 2025Q4 | -16.09% | -10.37 |
| 2025Q3 | -15.76% | -12.62 |
| 2025Q2 | 22.34% | 14.10 |
| 2025Q1 | -19.26% | -10.00 |
GLASF Free Cash Flow Yield and Dividend Yield
| Date | Free Cash Flow Yield | Dividend Yield |
|---|---|---|
| 2026Q1 | -2.12% | ? |
| 2025Q4 | -0.95% | 0.39% |
| 2025Q3 | -2.21% | 0.31% |
| 2025Q2 | 1.69% | 0.40% |
| 2025Q1 | -1.05% | 0.48% |
GLASF
Price: $11.81
52 week price:
Payout Ratio Range:
Earnings Per Share: -0.22 USD
P/E Ratio: -38.64
Exchange: OQX
Sector: Healthcare
Industry: Drug Manufacturers - Specialty & Generic
Market Capitalization: 851.8 million